Supporter Member - Bundesinstitut fuer Arzneimittel und Medizinprodukte
The BfArM, both on regulatory and research fields, works with the aim of preventing health risks by continuous improvement in the safety of medicinal products and by risk monitoring of medical devices as well as by controlling the traffic with narcotic drugs and precursors.
Research staff and students at Bundesinstitut fuer Arzneimittel und Medizinprodukte:
Do you realize that you will get a 15%
discount on the article-processing charges of all research articles accepted for publication in journals published by BioMed Central ? Read more information about publishing your articles with us.
Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Bundesinstitut fuer Arzneimittel und Medizinprodukte